154 related articles for article (PubMed ID: 30809981)
41. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
42. Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications.
Shin YK; Choi YL; Choi EY; Kim MK; Kook MC; Chung J; Choi YK; Kim HS; Song HG; Park SH
Cancer Immunol Immunother; 2003 Aug; 52(8):506-12. PubMed ID: 12768327
[TBL] [Abstract][Full Text] [Related]
43. Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.
Juárez-Avendaño G; Luna-Silva NC; Chargoy-Vivaldo E; Juárez-Martínez LA; Martínez-Rangel MN; Zárate-Ortiz N; Martínez-Valencia E; López-Martínez B; Pelayo R; Balandrán JC
Technol Cancer Res Treat; 2020; 19():1533033820928436. PubMed ID: 32608319
[TBL] [Abstract][Full Text] [Related]
44. [Detection of fusion gene--integral part of the assessment of children with acute leukemia].
Miron I; Ivanov A; Ivanov I; Dumitraş S
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):731-5. PubMed ID: 22046779
[TBL] [Abstract][Full Text] [Related]
45. Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.
Hwang I; Go H; Jeon YK; Ko YH; Yoon DH; Suh C; Huh JR; Lee H; Gil M; Park CS
Virchows Arch; 2011 Oct; 459(4):353-9. PubMed ID: 21814778
[TBL] [Abstract][Full Text] [Related]
46. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance.
Koehler M; Schell MJ; Behm FG; Raimondi SC; Woodruff LS; Mirro J
Leukemia; 1991 Jan; 5(1):41-8. PubMed ID: 1999957
[TBL] [Abstract][Full Text] [Related]
47. Analytical study of
Sepúlveda-Robles O; Jiménez-Hernández E; Domínguez-Catzín V; Gómez-Flores E; Martín-Trejo JA; Flores-Lujano J; Torres-Nava JR; Núñez-Enríquez JC; De Ita M; Medina-Sanson A; Mata-Rocha M; Morales-Castillo BA; Bravata-Alcántara JC; Nájera-Cortés AS; Sánchez-Escobar N; Peñaloza-Gonzalez JG; Espinosa-Elizondo RM; Flores-Villegas LV; Amador-Sanchez R; Orozco-Ruiz D; Pérez-Saldívar ML; Velázquez-Aviña MM; Merino-Pasaye LE; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; Bekker-Méndez VC; Jiménez-Morales S; Rangel-López A; Rosas-Vargas H; Mejía-Aranguré JM
Front Pediatr; 2022; 10():946690. PubMed ID: 36452349
[TBL] [Abstract][Full Text] [Related]
48. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.
Pui CH; Rubnitz JE; Hancock ML; Downing JR; Raimondi SC; Rivera GK; Sandlund JT; Ribeiro RC; Head DR; Relling MV; Evans WE; Behm FG
J Clin Oncol; 1998 Dec; 16(12):3768-73. PubMed ID: 9850020
[TBL] [Abstract][Full Text] [Related]
49. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
[TBL] [Abstract][Full Text] [Related]
50. Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells.
Park HJ; Jeon YK; Lee AH; Oh YH; Park SH; Jung KC
Am J Surg Pathol; 2012 Aug; 36(8):1150-7. PubMed ID: 22790855
[TBL] [Abstract][Full Text] [Related]
51. [Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia].
Kim SR; Kim HJ; Kim SH
Korean J Lab Med; 2009 Oct; 29(5):371-8. PubMed ID: 19893343
[TBL] [Abstract][Full Text] [Related]
52. Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.
Vergez F; Largeaud L; Bertoli S; Nicolau ML; Rieu JB; Vergnolle I; Saland E; Sarry A; Tavitian S; Huguet F; Picard M; Vial JP; Lechevalier N; Bidet A; Dumas PY; Pigneux A; Luquet I; Mansat-De Mas V; Delabesse E; Carroll M; Danet-Desnoyers G; Sarry JE; Récher C
Blood Cancer J; 2022 Aug; 12(8):117. PubMed ID: 35973983
[TBL] [Abstract][Full Text] [Related]
53. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
Abdulateef NA; Ismail MM; Aljedani H
Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotypic dysplasia and aberrant T-cell antigen expression in acute myeloid leukaemia with complex karyotype and
Dannheim KC; Pozdnyakova O; Dal Cin P; Weinberg OK
J Clin Pathol; 2018 Dec; 71(12):1051-1059. PubMed ID: 30171088
[TBL] [Abstract][Full Text] [Related]
56. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
[TBL] [Abstract][Full Text] [Related]
57. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.
Kanderova V; Kuzilkova D; Stuchly J; Vaskova M; Brdicka T; Fiser K; Hrusak O; Lund-Johansen F; Kalina T
Mol Cell Proteomics; 2016 Apr; 15(4):1246-61. PubMed ID: 26785729
[TBL] [Abstract][Full Text] [Related]
58. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
59. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
Klobusicka M; Kusenda J; Babusikova O
Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
[TBL] [Abstract][Full Text] [Related]
60. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
